Tag : ovarian

Latest News

Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in France

Newsemia
BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology Announces Availability and Reimbursement for Rubraca® (rucaparib) Tablets for Women with Relapsed Ovarian Cancer in France Source link...
Latest News

Elagolix drug suppresses ovarian hormone production, prevents heavy menstrual bleeding

Newsemia
About 50 % of women with uterine fibroids–non-cancerous muscle tumors that grow in the uterus–experience heavy menstrual bleeding and other symptoms. Surgery is commonly recommended...
Latest News

A protein found in ovarian cancer may contribute to neurodegeneration in Alzheimer's disease

Newsemia
Houston Methodist scientists identified a protein found in ovarian cancer that may contribute to declining brain function and Alzheimer’s disease, by combining computational methods and...
Latest News

Novel therapeutic approach improves survival in patients newly diagnosed with advanced ovarian cancer

Newsemia
An international study demonstrates that administering niraparib after conventional chemotherapy treatment in patients newly diagnosed with advanced ovarian cancer, improves their progression-free survival, and reduces...
Latest News

Clovis Oncology Highlights Rubraca® (rucaparib) Updated Data from the Ongoing TRITON2 Clinical Trial in Patients with mCRPC and Exploratory and Integrated Analyses in Recurrent Ovarian Cancer at the ESMO Congress 2019

Newsemia
BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology, Inc. (NASDAQ: CLVS) today announced updated data from the Phase 2 TRITON2 trial at the European Society for Medical Oncology (ESMO)...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy